91 related articles for article (PubMed ID: 7104858)
1. A comparison of some pharmacological effects of naloxone and N-methylnaloxone in mice.
Ramabadran K; Suaudeau C; Jacob JJ
Can J Physiol Pharmacol; 1982 May; 60(5):715-9. PubMed ID: 7104858
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice.
Ramabadran K
Life Sci; 1982 Sep 20-27; 31(12-13):1253-6. PubMed ID: 6183549
[TBL] [Abstract][Full Text] [Related]
3. Effect of naloxone-3-glucuronide and N-methylnaloxone on the motility of the isolated rat colon after morphine.
Reber P; Brenneisen R; Flogerzi B; Batista C; Netzer P; Scheurer U
Dig Dis Sci; 2007 Feb; 52(2):502-7. PubMed ID: 17211696
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system.
Agmo A; Rojas J; Vázquez P
Psychopharmacology (Berl); 1992; 107(1):89-96. PubMed ID: 1317041
[TBL] [Abstract][Full Text] [Related]
5. Differential antinociceptive effects of morphine and methylmorphine in the formalin test.
Oluyomi AO; Hart SL; Smith TW
Pain; 1992 Jun; 49(3):415-418. PubMed ID: 1408307
[TBL] [Abstract][Full Text] [Related]
6. Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives.
Brown DR; Robertson MJ; Goldberg LI
Neuropharmacology; 1983 Mar; 22(3):317-21. PubMed ID: 6682490
[TBL] [Abstract][Full Text] [Related]
7. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
8. An etorphine-evoked vagal reflex in rats is inhibited by naloxone, N-methylnaloxone, and SMS 201-995.
Dashwood MR; Kiang JG; Wei ET
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):77-82. PubMed ID: 6198981
[TBL] [Abstract][Full Text] [Related]
9. Opioid agonist and antagonist properties of diastereoisomeric N-tetrahydronoroxymorphones in mice.
Ramabadran K; Jen MF
Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):180-8. PubMed ID: 4040738
[TBL] [Abstract][Full Text] [Related]
10. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
Pircio AW; Gylys JA
J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
[TBL] [Abstract][Full Text] [Related]
11. Effects of ICI204,448, naloxone methiodide and levocetirizine on the scratching behavior induced by a κ-opioid antagonist, nor-BNI, in ICR mice.
Nakasone T; Wakuda H; Sugimoto Y; Kamei C
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):292-295. PubMed ID: 28745076
[TBL] [Abstract][Full Text] [Related]
12. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
[TBL] [Abstract][Full Text] [Related]
13. [The reactivity of laboratory mice in pharmacological tests as dependent on their zoosocial status].
Vekovishcheva OIu; Zvartau EE
Eksp Klin Farmakol; 1999; 62(1):6-10. PubMed ID: 10198756
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of a nociceptive reaction by opioid antagonists in mice.
Jacob JJ; Ramabadran K
Br J Pharmacol; 1978 Sep; 64(1):91-8. PubMed ID: 698486
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
Caruso TP; Larson DL; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
[TBL] [Abstract][Full Text] [Related]
16. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
17. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
Hahn EF; Itzhak Y; Nishimura S; Johnson N; Pasternak GW
J Pharmacol Exp Ther; 1985 Dec; 235(3):846-50. PubMed ID: 2416910
[TBL] [Abstract][Full Text] [Related]
18. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
[No Abstract] [Full Text] [Related]
19. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
Hahn EF; Nishimura S; Goodman RR; Pasternak GW
J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
[TBL] [Abstract][Full Text] [Related]
20. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
